@article{9a3bf3ec2b5a434d8bf523953d85e145,
title = "Protocol for Development of American Association of Clinical Endocrinology Clinical Practice Guidelines and Consensus Statements: Summary of Methodology, Process, and Policy – 2023 Update",
abstract = "Objective: This 2023 updated protocol summarizes the American Association of Clinical Endocrinology's (AACE's) new framework for the development of clinical practice guidelines and other guidance documents that includes changes to methodology, processes, and policies. Methods: AACE has critically reviewed its development processes for guidance documents over the last several years against the National Academy of Medicine Standards for Developing Trustworthy Clinical Practice Guidelines and the Council of Medical Specialty Societies Principles for Development of Specialty Society Clinical Guidelines to determine areas for improvement. Results: The new AACE framework for development of guidance documents incorporates many changes, including a revised conflicts of interest (COI) policy; strengthened commitment to collection of disclosures and management of relevant COI during development; open calls to membership for authors; new requirements for authors; new diversity, equity, and inclusion (DEI) policy; new empanelment process that incorporates consideration of DEI; and adoption of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology to increase the quality of evidence assessment and standardize recommendation grades and statements, among other improvements. Conclusions: AACE has revised its policies and adopted a completely new methodology for guideline development in support of the mission to elevate the practice of clinical endocrinology to improve patient care. With the use of an evidence-based medicine framework and by continually assessing and improving its processes for development of guidance, AACE strives to deliver trustworthy, unbiased, and up-to-date information that ensures clinician and patient confidence in AACE content. Further, AACE hopes that these enhancements foster a more collaborative approach to development and increase engagement with the worldwide medical community to improve global health.",
keywords = "clinical practice guidelines, conflicts of interest, consensus statements, diversity, equity, inclusion, methodology, patient care",
author = "{Clinical Practice Guidelines Oversight Committee} and Ricardo Correa and Joanna Miragaya and Cohen, {David A.} and Hoang, {Thanh D.} and Sina Jasim and Lieb, {David C.} and Weber, {Sandra L.} and Bird, {Melanie D.} and Carla Stec",
note = "Funding Information: We first thank all the dedicated AACE members who created the foundation for development of AACE clinical guidance, starting with the Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines in 2004, which consisted of the following members: Jeffrey I. Mechanick (Chairperson), Donald A. Bergman, Susan Shapiro Braithwaite, and Pasquale J. Palumbo. We thank the authors of the 2010 protocol: Jeffrey I. Mechanick, Pauline M. Camacho, Rhoda H. Cobin, Alan J. Garber, Jeffrey R. Garber, Hossein Gharib, Steven M. Petak, Helena W. Rodbard, and Dace L. Trence; the 2014 protocol: Jeffrey I. Mechanick, Pauline M. Camacho, Alan J. Garber, Jeffrey R. Garber, Rachel Pessah-Pollack, Steven M. Petak, Vin Tangpricha, and Dace L. Trence; and the 2017 protocol: Jeffrey I. Mechanick, Rachel Pessah-Pollack, Pauline Camacho, Ricardo Correa, M. Kathleen Figaro, Jeffrey R. Garber, Sina Jasim, Kevin M. Pantalone, Dace Trence, and Sikarin Upala. We thank all members of the AACE Clinical Practice Guidelines Oversight Committee, Guideline Strategic Task Force, Guideline Development Workgroup, and staff who were involved in shaping new priorities and tactics, adopting new methodology, and refining procedures for the last several years to transform the AACE guidance program so that documents are systematically developed, evidence based, unbiased, easily accessible, dynamic, and uniform for clinicians, patients, caregivers, payers, and other stakeholders. We are especially grateful to the AACE Executive Committee, Board of Directors, and Executive Leadership Team who embraced innovation, thoughtfully considered recommendations, and supported change. R.C. and J.M. are co-first authors. M.D.B. and C.S. are co-senior authors. Drafts of this protocol update were reviewed and approved by all writing group members, the AACE CPG Oversight Committee, the AACE Board of Directors, and peer reviewers for Endocrine Practice. AACE received no outside funding for the development of this document and solely supports the development of all AACE clinical practice guidelines and consensus statements. Publisher Copyright: {\textcopyright} 2023 AACE",
year = "2023",
month = may,
doi = "10.1016/j.eprac.2023.01.012",
language = "English",
volume = "29",
pages = "341--348",
journal = "Endocrine Practice",
issn = "1530-891X",
number = "5",
}